APA (7th ed.) Citation

Lee, J. Y., Reyes, N. S., Ravishankar, S., Zhou, M., Krasilnikov, M., Ringler, C., . . . Peng, T. (2024). An in vivo screening platform identifies senolytic compounds that target p16INK4a+ fibroblasts in lung fibrosis. The Journal of clinical investigation, 134(9), 1-16. https://doi.org/10.1172/JCI173371

Chicago Style (17th ed.) Citation

Lee, Jin Young, et al. "An in Vivo Screening Platform Identifies Senolytic Compounds That Target P16INK4a+ Fibroblasts in Lung Fibrosis." The Journal of Clinical Investigation 134, no. 9 (2024): 1-16. https://doi.org/10.1172/JCI173371.

MLA (9th ed.) Citation

Lee, Jin Young, et al. "An in Vivo Screening Platform Identifies Senolytic Compounds That Target P16INK4a+ Fibroblasts in Lung Fibrosis." The Journal of Clinical Investigation, vol. 134, no. 9, 2024, pp. 1-16, https://doi.org/10.1172/JCI173371.